Search

Your search keyword '"Watase, Mayuko"' showing total 48 results

Search Constraints

Start Over You searched for: Author "Watase, Mayuko" Remove constraint Author: "Watase, Mayuko"
48 results on '"Watase, Mayuko"'

Search Results

1. Prognostic significance of hypertension history and blood pressure on admission in Japanese patients with coronavirus disease 2019: integrative analysis from the Japan COVID-19 Task Force

2. Chronic obstructive pulmonary disease, asthma, and mechanical ventilation are risk factors for dyspnea in patients with long COVID: A Japanese nationwide cohort study

3. Association between ABO blood group/genotype and COVID-19 in a Japanese population

4. CT-derived vertebral bone mineral density is a useful biomarker to predict COVID-19 outcome

5. Asthma is a risk factor for general fatigue of long COVID in Japanese nation-wide cohort study

6. Integrated assessment of computed tomography density in pectoralis and erector spinae muscles as a prognostic biomarker for coronavirus disease 2019

7. Characteristics of patients with COVID-19 who have deteriorating chest X-ray findings within 48 h: a retrospective cohort study

8. Clinical utilization of artificial intelligence-based COVID-19 pneumonia quantification using chest computed tomography – a multicenter retrospective cohort study in Japan

9. Impact of respiratory bacterial infections on mortality in Japanese patients with COVID-19: a retrospective cohort study

10. Epicardial adipose tissue measured from analysis of adipose tissue area using chest CT imaging is the best potential predictor of COVID-19 severity

11. Comprehensive analysis of long COVID in a Japanese nationwide prospective cohort study

12. Impact of accumulative smoking exposure and chronic obstructive pulmonary disease on COVID-19 outcomes: report based on findings from the Japan COVID-19 task force

13. U-shaped association between abnormal serum uric acid levels and COVID-19 severity: reports from the Japan COVID-19 Task Force

14. Real-World Efficacy and Safety of Atezolizumab for Advanced Non-Small Cell Lung Cancer in Japan: A Retrospective Multicenter Analysis.

15. Impact of upper and lower respiratory symptoms on COVID-19 outcomes: a multicenter retrospective cohort study

16. Clinical clustering with prognostic implications in Japanese COVID-19 patients: report from Japan COVID-19 Task Force, a nation-wide consortium to investigate COVID-19 host genetics

17. Effects of mild obesity on outcomes in Japanese patients with COVID-19: a nationwide consortium to investigate COVID-19 host genetics

18. Characteristics of hospitalized patients with COVID-19 during the first to fifth waves of infection: a report from the Japan COVID-19 Task Force

19. Prognostic significance of chronic kidney disease and impaired renal function in Japanese patients with COVID-19

20. Combined use of serum ferritin and KL-6 levels as biomarkers for predicting COVID-19 severity

21. Corrigendum to ‘Impact of accumulative smoking exposure and chronic obstructive pulmonary disease on COVID-19 outcomes: report based on findings from the Japan COVID-19 task force’ [IJID 128 (2023) 121–127]

22. Longitudinal long COVID symptoms in Japanese patients after COVID-19 vaccinations

23. Cough and sputum in long COVID are associated with severe acute COVID-19: a Japanese cohort study

24. Asthma is a risk factor for general fatigue of long COVID in Japanese nation-wide cohort study

25. Clinical characteristics of patients with COVID-19 harboring detectable intracellular SARS-CoV-2 RNA in peripheral blood cells

26. Propensity-Score Matched Analysis of the Effectiveness of Baricitinib in Patients With Coronavirus Disease 2019 (COVID-19) Using Nationwide Real-World Data: An Observational Matched Cohort Study From the Japan COVID-19 Task Force

27. Serum KL-6 levels predict clinical outcomes and are associated withMUC1polymorphism in Japanese patients with COVID-19

28. Characteristics and Clinical Effectiveness of COVID-19 Vaccination in Hospitalized Patients in Omicron-dominated Epidemic Wave – A Nationwide Study in Japan

29. Use of the neutrophil-to-lymphocyte ratio and an oxygen requirement to predict disease severity in patients with COVID-19

30. Diagnostic and prognostic biomarkers for progressive fibrosing interstitial lung disease

31. Additional file 8 of Impact of respiratory bacterial infections on mortality in Japanese patients with COVID-19: a retrospective cohort study

32. Additional file 6 of Impact of respiratory bacterial infections on mortality in Japanese patients with COVID-19: a retrospective cohort study

33. Additional file 4 of Impact of respiratory bacterial infections on mortality in Japanese patients with COVID-19: a retrospective cohort study

34. Additional file 5 of Impact of respiratory bacterial infections on mortality in Japanese patients with COVID-19: a retrospective cohort study

35. Additional file 2 of Impact of respiratory bacterial infections on mortality in Japanese patients with COVID-19: a retrospective cohort study

36. Additional file 1 of Impact of respiratory bacterial infections on mortality in Japanese patients with COVID-19: a retrospective cohort study

37. Additional file 7 of Impact of respiratory bacterial infections on mortality in Japanese patients with COVID-19: a retrospective cohort study

38. Additional file 3 of Impact of respiratory bacterial infections on mortality in Japanese patients with COVID-19: a retrospective cohort study

39. Characteristics of patients with COVID-19 who have deteriorating chest X-ray findings within 48 hours: a retrospective cohort study

40. Diagnostic significance of secondary bacteremia in patients with COVID-19

41. Association between ABO blood group/genotype and COVID-19 in a Japanese population

42. Additional file 1 of Impact of upper and lower respiratory symptoms on COVID-19 outcomes: a multicenter retrospective cohort study

43. Comprehensive Analysis of Long COVID in a Japanese Nationwide Prospective Cohort Study

44. Clinical Clustering with Prognostic Implications in Japanese COVID-19 Patients: Report from Japan COVID-19 Task Force, a Nation-Wide Consortium to Investigate COVID-19 Host Genetics

45. An Adult Case of Pulmonary Artery Sling Accompanied by Tracheobronchomalacia

46. Long COVID among the first three waves of COVID-19 in Japan: a multicentre cohort study.

47. Lung volume measurement using chest CT in COVID-19 patients: a cohort study in Japan.

48. Serum KL-6 levels predict clinical outcomes and are associated with MUC1 polymorphism in Japanese patients with COVID-19.

Catalog

Books, media, physical & digital resources